Source: BUSINESS WIRE

Press Release: Promedior : Research and Markets: Proliferative Vitreoretinopathy (PVR) Pipeline Review, H2 2015 - 2 Companies & 7 Drug Profiles

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/jb2qxk/proliferative) has announced the addition of the "Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Proliferative Vitreoretinopathy (PVR), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administr

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Estimated Annual Revenue

Estimated Employees

Jason Lettmann's photo - CEO of Promedior

CEO

Jason Lettmann

CEO Approval Rating

90/100

Promedior is a clinical-stage biotechnology company that develops and commercializes novel therapeutics for the treatmen... Read more